chr16-8847806-GT-CA

Variant summary

Our verdict is Uncertain significance.
+4 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 4 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO7_SupportingO8_Supporting

The NM_000303.3(PMM2):c.722_723delGTinsCA (p.Cys241Ser) variant causes a missense change. The gene PMM2 is a cancer driver gene (CancerMine: 2 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.25). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.C241R: Likely_pathogenic (ClinVar VariationId 2847057, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: not found (cov: 33)

Consequence

PMM2
NM_000303.3 missense

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 8.25

Publications

0 publications found
Variant links:
Genes affected
PMM2 (HGNC:9115): (phosphomannomutase 2) The protein encoded by this gene catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate, which is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in this gene have been shown to cause defects in glycoprotein biosynthesis, which manifests as carbohydrate-deficient glycoprotein syndrome type I. [provided by RefSeq, Jul 2008]
PMM2 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation type I
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women's Health
  • PMM2-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Natera, PanelApp Australia, Orphanet, ClinGen
  • hyperinsulinemic hypoglycemia with polycystic kidney disease
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000303.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 4 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 8 pathogenic, 1 benign (OR vs. background: 28.3); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: -1.80 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000303.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

PMM2 NM_000303.3
MANE Select
HGVSc / HGVSpc.722_723delGTinsCAp.Cys241Ser
Exon rankN/A
missense
Prot: NP_000294.1UniProt: O15305-1A0A0S2Z4J6

Ensembl Transcripts

PMM2 ENST00000268261.9
TSL:1MANE Select
HGVSc / HGVSpc.722_723delGTinsCAp.Cys241Ser
Exon rankN/A
missense
Prot: ENSP00000268261.4UniProt: O15305-1
PMM2 ENST00000565221.5
TSL:1
HGVSc / HGVSpn.*340_*341delGTinsCA
Exon rankExon 6 of 6
3_prime_UTR
Prot: ENSP00000457932.1UniProt: H3BV34
PMM2 ENST00000566540.5
TSL:1
HGVSc / HGVSpn.*344_*345delGTinsCA
Exon rankExon 6 of 6
3_prime_UTR
Prot: ENSP00000454284.1UniProt: H3BM92

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 2 sources
GnomAD3 genomes
Cov:33
GnomAD4 genome
Cov:33
Showing 2 sources

ClinVar

Not reported in ClinVar

Computational Scores

PhyloP100
Pathogenic8.3
Showing 1 of 1 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.